The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 ...

Semaglutide is linked to a reduced risk for Alzheimer’s disease-related dementia in patients with diabetes vs other ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes patients.

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

Men with high levels of belly fat are at increased risk of dementia, according to a new study by Monash University ...

Semaglutide has been associated with “slowing dementia development” among people living with type 2 diabetes, new research ...

Alzheimer’s disease continues to rise as one of the most pressing health challenges facing aging populations today. It ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

For years, scientists have believed that inflammation inevitably increases with age, quietly fuelling diseases like heart ...

Beyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...

Men who carry too much weight around the belly are at greater risk of developing dementia, a large Australian study warns.